IV proton pump inhibitors are typically indicated for which clinical scenario?

• A. Gastric ulcer bleeding
• B. GERD without bleeding
• C. Chronic gastritis without bleeding
• D. Peptic ulcer prophylaxis with no bleeding

Answer: (A)

In this scenario, the main idea is that IV proton pump inhibitors are used when there is an active peptic ulcer–related GI bleed. This IV route provides rapid suppression of gastric acid, which helps stabilize the clot and reduce the risk of rebleeding. That makes the scenario of a gastric ulcer with bleeding the one where IV PPI therapy is typically indicated, often started promptly and continued for a short course to control bleeding and support healing.

For the other situations, IV PPI is not the standard initial choice. GERD without bleeding is usually managed with oral PPI therapy for acid suppression. Chronic gastritis without bleeding doesn’t require IV PPI unless there are specific complications or inability to take oral meds. Prophylaxis for ulcers without bleeding isn’t a typical indication for IV PPI therapy unless there’s a high-risk scenario like stress ulcer prevention in critically ill patients, which is a different context from routine nonbleeding cases.